Last updated on November 2019

A Study to Evaluate the Pharmacokinetics Safety and Tolerability of Upadacitinib in Pediatric Subjects With Severe Atopic Dermatitis


Brief description of study

The primary objective of this study is to evaluate the safety, pharmacokinetics and tolerability of multiple doses of upadacitinib in pediatric subjects with severe atopic dermatitis.

Clinical Study Identifier: NCT03646604

Find a site near you

Start Over